Skip to main content

Corum Client Carenity Acquired by BID Equity

Written by Customer Service on . Posted in Mergers And Acquisitions.

SEATTLE, Feb. 01, 2021 (GLOBE NEWSWIRE) — Corum announces that their client, France-based Carenity, the developer of a social platform supporting patients and caregivers, has been acquired by German Private Equity firm BID Equity. BID Equity is merging three of its portfolio companies—XClinical, Fortress Medical Systems and Carenity—creating a new data science company delivering end-to-end coverage of the clinical development process.
“The M&A process with Carenity started in March, and despite the global pandemic, there was very strong interest from strategic life sciences acquirers as well as several private equity funds, seeking bolt-on deals. By creating a global demand for Carenity, Corum’s process allowed our client to choose the right buyer among many interested parties,” explains Corum Senior Vice President Jaber Tannay, who led the deal. “We are happy that our client chose BID Equity. They are the ones that are likely to generate the most synergies from this transaction considering their bolt-on acquisition strategy.”Corum will further discuss this deal and the overall M&A market for software and related technology companies during Corum’s monthly webcast on February 11th: Private Equity Panel Discussion.About Corum Group
Corum Group is the global leader in merger and acquisition services, specializing in serving sellers of software and related technology companies worldwide. With offices globally, Corum has completed over $10B in software M&A transactions over the last 36 years. Corum’s M&A advisors are highly experienced former tech CEOs, supported by industry-leading researchers, writers and valuators. Corum is the leading tech M&A educator worldwide with its popular conferences and publishes the most widely distributed software M&A research. For more information, visit www.corumgroup.com.About Carenity
Carenity is a leading social platform supporting 500,000 patients and caregivers worldwide, across 1,000 chronic and rare diseases. Through its award-winning platform and data science expertise, Carenity provides direct, timely and compliant access to patient real-world data. Founded in 2011 and headquartered in Paris, Carenity offers unique solutions for Real-World Evidence, Clinical Trial Optimization as well as Scientific Communication. Visit www.carenity.us to learn more.About BID Equity
BID Equity is a new generation Private Equity firm investing in software and technology companies in Europe. We consider ourselves a partner for entrepreneurs and management teams, believing in active ownership and operational value creation to help companies reach the next level of their development. The BID Equity team contributes a unique set of capabilities and expertise well beyond the contribution of traditional financial investors to its portfolio firms. To learn more, visit www.bidequity.de.Contact:
Heidi Owen
+1 425-526-3107
heidio@corumgroup.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.